Bioteque Corporation (TPEX:4107)
121.50
+0.50 (0.41%)
At close: Dec 26, 2025
Bioteque Market Cap
Bioteque has a market cap or net worth of 8.42 billion as of December 26, 2025. Its market cap has decreased by -3.95% in one year.
Market Cap
8.42B
Enterprise Value
7.54B
Revenue
2.07B
Ranking
n/a
PE Ratio
16.33
Stock Price
121.50
Market Cap Chart
Since November 3, 2004, Bioteque's market cap has increased from 442.84M to 8.42B, an increase of 1,801.32%. That is a compound annual growth rate of 14.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 8.39B | -2.02% |
| Dec 31, 2024 | 8.56B | 12.27% |
| Dec 29, 2023 | 7.62B | -1.35% |
| Dec 30, 2022 | 7.73B | -2.62% |
| Dec 30, 2021 | 7.93B | -13.91% |
| Dec 31, 2020 | 9.22B | 1.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 244.27B |
| PharmaEssentia | 181.23B |
| Heron Neutron Medical | 75.90B |
| Lotus Pharmaceutical | 73.24B |
| Bora Pharmaceuticals Co., LTD. | 61.15B |
| Lin BioScience | 33.09B |
| Lumosa Therapeutics | 31.08B |
| Oneness Biotech | 27.75B |